{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Irritable Bowel Syndrome: Current and Emerging Therapies

Description

NOTE: This activity requires payment before viewing.

Purpose of Activity

To provide a summary of current evidence-based management strategies for individuals with irritable bowel syndrome.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the symptoms, differential diagnoses, and diagnostic criteria of irritable bowel syndrome.
  2. Explain the potential role of neural, endocrine, immune, and metabolic alterations that affect irritable bowel syndrome symptoms.
  3. Compare and contrast the different subtypes of irritable bowel syndrome and management strategies for treatment of irritable bowel syndrome.
Price: $49.00

Credits:

  • ANCC 1.0 CH / 0.5 APH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: TPM0919
Published: Sep 2019
Expires: 9/3/2021
Passing Score: 7/10 (70%)
Authors: Angela Starkweather, PhD, ACNP-BC, CNRN, FAAN